A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Chinese Adults With Chronic Coronary Syndrome

Abroad (travel likely)RecruitingPHASE1

Conditions

Chronic Coronary Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Anzhen Hospital, Beijing, China

Study leads
  • Clinical Trials

    Study Director

    Viatris Innovation GmbH